You searched for "prostatectomy"
Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy
1 May 2017
| Pravisha Ravindra
|
URO - Urologic Oncology
Neutrophil-to-lymphocyte ratio has been shown to be a prognostic factor in a number of different cancers. This is one of the largest studies to date to evaluate its effect on overall survival in patients who have undergone radical prostatectomy (RP)...
Robotic assisted perineal prostatectomy: descriptive technique of the inaugural case in the UK
1 January 2019
| Jonathan Noël, Bradley Russell, Christopher Ogden, Jihad Kaouk
|
URO - Urologic Oncology, URO - Technology
Robotic surgery has taken full flight in the USA since its start in 2000 [1] and is replacing procedures where open surgical techniques were solely employed. While this technology is met with criticism over the costs, the superiority of robotic...
Adjuvant radiotherapy versus wait-and-see after radical prostatectomy
1 September 2014
| Sophia Cashman
|
URO - Urologic Oncology
Optimum treatment modalities in prostate cancer continue to evolve, with debates at each stage of the evolution process, from focal therapy to radical treatment. In this randomised study, Wiegel et al. investigated the role of adjuvant radiotherapy following open radical...
Testosterone supplementation after prostatectomy – journey from bad to good
The role of androgens in the pathogenesis of prostate cancer is quite complex and is not entirely clear yet. Despite several reports suggesting testosterone use is safe in patients diagnosed with prostate cancer, many clinicians are still reluctant to use...Catheters and incontinence after radical prostatectomy: Preparing (but not scaring) men
1 May 2018
| Margaret Macaulay, Kelly Hislop Lennie, Sinead Clark-O’Neill, Mandy Fader
|
URO - Infection, URO - Functional / Reconstructive Urology, URO - Urologic Oncology
Every year about 6000 men in the UK undergo radical prostatectomy (RP) for treatment of prostate cancer [1]. Despite surgical advances, RP continues to be associated with significant side-effects including urinary incontinence (UI) [2]. Immediately following removal of the urinary...
Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade
1 September 2019
| Pravisha Ravindra
|
URO - Urologic Oncology
This is an interesting paper reporting on the use of neoadjuvant androgen blockage in patients with high-risk prostate cancer undergoing radical prostatectomy. Previous work in the literature has shown an improvement in the rate of organ-confined disease and decreased positive...
Testing radical prostatectomy in men with prostate cancer and oligometastases to the bone: a randomised controlled feasibility study
1 May 2017
| Prasanna Sooriakumaran
|
URO - Urologic Oncology
Prostate cancer is the commonest cancer and the second most frequent cause of cancer death in Western men [1]. The recent STAMPEDE data suggests a median survival of just 42.1 months in the control arm of metastatic men [2]. Current...
Demanding cases or nightmares in uro-oncology? Sep/Oct 2022
5 September 2022
| Vincent Chong
|
URO - Urologic Oncology
Treatment of prostate cancer in renal transplant recipients is challenging due to a lack of knowledge of the natural history of cancer in these patients, the anatomical position of the graft in the iliac fossa and its proximity to the...
ORSI Academy Robot-Assisted Radical Prostatectomy - Advanced Course
7 October 2024
-8 October 2024
Dilemma of second primary tumour
1 May 2019
| Arun K Sharma
|
URO - Urologic Oncology
Long-term survival in localised prostate cancer (CaP) can be achieved with treatment by either radical prostatectomy (RP) or external beam radiotherapy (EBRT). The development of second primary tumour is poorly understood in such cases. This retrospective study included 84,397 cases...
Morbidity and mortality after surgery for LUTS
1 September 2017
| Pravisha Ravindra
|
URO - Urologic Oncology
The market for bladder outflow obstruction surgery is currently wide open with new technologies such as Urolift® emerging. One of the key selling points of new technologies is the comparative safety and efficacy compared to traditional techniques such as transurethral...
